Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04541407
Title Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Colorado, Denver
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST